{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T23:35:07Z","timestamp":1780529707377,"version":"3.54.1"},"reference-count":56,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.3892\/mco.2014.293","type":"journal-article","created":{"date-parts":[[2014,5,15]],"date-time":"2014-05-15T10:22:06Z","timestamp":1400149326000},"page":"509-517","source":"Crossref","is-referenced-by-count":53,"title":["Prognostic significance of the co-overexpression of fibroblast growth factor receptors 1, 2 and 4 in gastric cancer"],"prefix":"10.3892","volume":"2","author":[{"given":"HIDEAKI","family":"MURASE","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MIKITO","family":"INOKUCHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YOKO","family":"TAKAGI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KEIJI","family":"KATO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KAZUYUKI","family":"KOJIMA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KENICHI","family":"SUGIHARA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2014,5,15]]},"reference":[{"key":"key20180107150750_b1-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"key20180107150750_b2-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/978-1-60327-492-0_23","article-title":"Epidemiology of stomach cancer","volume":"472","author":"Brenner","year":"2009","journal-title":"Methods Mol Biol"},{"key":"key20180107150750_b3-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(09)60617-6","article-title":"Gastric cancer","volume":"374","author":"Hartgrink","year":"2009","journal-title":"Lancet"},{"key":"key20180107150750_b4-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa073149","article-title":"Capecitabine and oxaliplatin for advanced esophagogastric cancer","volume":"358","author":"Cunningham","year":"2008","journal-title":"N Engl J Med"},{"key":"key20180107150750_b5-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet"},{"key":"key20180107150750_b6-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1093\/annonc\/mdn169","article-title":"HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target","volume":"19","author":"Gravalos","year":"2008","journal-title":"Ann Oncol"},{"key":"key20180107150750_b7-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1365-2559.2008.03028.x","article-title":"Assessment of a HER2 scoring system for gastric cancer: results from a validation study","volume":"52","author":"Hofmann","year":"2008","journal-title":"Histopathology"},{"key":"key20180107150750_b8-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0092-8674(87)90110-3","article-title":"Synergistic induction of mesoderm by FGF and TGF-beta and the identification of an mRNA coding for FGF in the early Xenopus embryo","volume":"51","author":"Kimelman","year":"1987","journal-title":"Cell"},{"key":"key20180107150750_b9-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1242\/dev.127.3.483","article-title":"An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis","volume":"127","author":"De Moerlooze","year":"2000","journal-title":"Development"},{"key":"key20180107150750_b10-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nrc2780","article-title":"Fibroblast growth factor signalling: from development to cancer","volume":"10","author":"Turner","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"key20180107150750_b11-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1158\/0008-5472.CAN-07-5229","article-title":"FGFR2-amplified gastric cancer cell lines require FGFR2 and Erbb3 signaling for growth and survival","volume":"68","author":"Kunii","year":"2008","journal-title":"Cancer Res"},{"key":"key20180107150750_b12-mco-02-04-0509","first-page":"875","article-title":"Co-expression of keratinocyte growth factor and K-sam is an independent prognostic factor in gastric carcinoma","volume":"21","author":"Toyokawa","year":"2009","journal-title":"Oncol Rep"},{"key":"key20180107150750_b13-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.1158\/1078-0432.CCR-10-0531","article-title":"Monoclonal antibodies to fibroblast growth factor receptor 2 effectively inhibit growth of gastric tumor xenografts","volume":"16","author":"Zhao","year":"2010","journal-title":"Clin Cancer Res"},{"key":"key20180107150750_b14-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1158\/1535-7163.MCT-11-0306","article-title":"A novel, selective inhibitor of fibroblast growth factor receptors that shows a potent broad spectrum of antitumor activity in several tumor xenograft models","volume":"10","author":"Zhao","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"key20180107150750_b15-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1158\/1078-0432.CCR-11-0699","article-title":"Molecular pathways: fibroblast growth factor signaling: a new therapeutic opportunity in cancer","volume":"18","author":"Brooks","year":"2012","journal-title":"Clin Cancer Res"},{"key":"key20180107150750_b16-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s004320000128","article-title":"Up-regulation and co-expression of fibroblast growth factor receptors in human gastric cancer","volume":"126","author":"Shin","year":"2000","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20180107150750_b17-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.3748\/wjg.14.5650","article-title":"Overexpression of the receptor tyrosine kinase EphA4 in human gastric cancers","volume":"14","author":"Oki","year":"2008","journal-title":"World J Gastroenterol"},{"key":"key20180107150750_b18-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1245\/s10434-010-1323-6","article-title":"The fibroblast growth factor receptor-4 Arg388 allele is associated with gastric cancer progression","volume":"17","author":"Ye","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"key20180107150750_b19-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"5304","DOI":"10.1002\/cncr.26207","article-title":"Fibroblast growth factor receptor 4 regulates proliferation and antiapoptosis during gastric cancer progression","volume":"117","author":"Ye","year":"2011","journal-title":"Cancer"},{"key":"key20180107150750_b20-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cytogfr.2005.01.001","article-title":"Cellular signaling by fibroblast growth factor receptors","volume":"16","author":"Eswarakumar","year":"2005","journal-title":"Cytokine Growth Factor Rev"},{"key":"key20180107150750_b21-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"18320","DOI":"10.1016\/S0021-9258(17)32309-8","article-title":"Signal transduction by fibroblast growth factor receptor-4 (FGFR-4). Comparison with FGFR-1","volume":"269","author":"Vainikka","year":"1994","journal-title":"J Biol Chem"},{"key":"key20180107150750_b22-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1128\/MCB.14.1.181","article-title":"Fibroblast growth factor receptors have different signaling and mitogenic potentials","volume":"14","author":"Wang","year":"1994","journal-title":"Mol Cell Biol"},{"key":"key20180107150750_b23-mco-02-04-0509","first-page":"1553","article-title":"Fibroblast growth factor receptors display both common and distinct signaling pathways","volume":"10","author":"Shaoul","year":"1995","journal-title":"Oncogene"},{"key":"key20180107150750_b24-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1210\/me.2006-0518","article-title":"Distinct roles of fibroblast growth factor receptor 1 and 2 in regulating cell survival and epithelial mesenchymal transition","volume":"21","author":"Xian","year":"2007","journal-title":"Mol Endocrinol"},{"key":"key20180107150750_b25-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1158\/0008-5472.CAN-09-3746","article-title":"FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer","volume":"70","author":"Turner","year":"2010","journal-title":"Cancer Res"},{"key":"key20180107150750_b26-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/gcc.2870070407","article-title":"FGFRI and PLAT genes and DNA amplification at 8p12 in breast and ovarian cancers","volume":"7","author":"Theillet","year":"1993","journal-title":"Genes Chromosomes Cancer"},{"key":"key20180107150750_b27-mco-02-04-0509","first-page":"4514","article-title":"High-throughput tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1) copy number alterations in urinary bladder cancer","volume":"61","author":"Simon","year":"2001","journal-title":"Cancer Res"},{"key":"key20180107150750_b28-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"62ra93","DOI":"10.1126\/scitranslmed.3001451","article-title":"Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer","volume":"2","author":"Weiss","year":"2010","journal-title":"Sci Transl Med"},{"key":"key20180107150750_b29-mco-02-04-0509","first-page":"211","article-title":"Overexpression of the fibroblast growth factor receptor-1 gene correlates with liver metastasis in colorectal cancer","volume":"21","author":"Sato","year":"2009","journal-title":"Oncol Rep"},{"key":"key20180107150750_b30-mco-02-04-0509","first-page":"557","article-title":"Co-expression of aFGF and FGFR-1 is predictive of a poor prognosis in patients with esophageal squamous cell carcinoma","volume":"17","author":"Sugiura","year":"2007","journal-title":"Oncol Rep"},{"key":"key20180107150750_b31-mco-02-04-0509","first-page":"840","article-title":"Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele","volume":"62","author":"Bange","year":"2002","journal-title":"Cancer Res"},{"key":"key20180107150750_b32-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1200\/JCO.2005.04.8587","article-title":"FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer","volume":"24","author":"Thussbas","year":"2006","journal-title":"J Clin Oncol"},{"key":"key20180107150750_b33-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"E586","DOI":"10.1002\/ijc.27329","article-title":"Fibroblast growth factor receptor 4 gene (FGFR4) 388Arg allele predicts prolonged survival and platinum sensitivity in advanced ovarian cancer","volume":"131","author":"Marm\u00e9","year":"2012","journal-title":"Int J Cancer"},{"key":"key20180107150750_b34-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/CEJ.0b013e3283457274","article-title":"Meta and pooled analyses of FGFR4 Gly388Arg polymorphism as a cancer prognostic factor","volume":"20","author":"Frullanti","year":"2011","journal-title":"Eur J Cancer Prev"},{"key":"key20180107150750_b35-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/ijc.2910590515","article-title":"Expression and functional activity of fibroblast growth factors and their receptors in human pancreatic cancer","volume":"59","author":"Leung","year":"1994","journal-title":"Int J Cancer"},{"key":"key20180107150750_b36-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1006\/bbrc.1999.0465","article-title":"Identification of receptor genes in renal cell carcinoma associated with angiogenesis by differential hybridization technique","volume":"257","author":"Takahashi","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107150750_b37-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"5983","DOI":"10.1073\/pnas.87.15.5983","article-title":"K-sam, an amplified gene in stomach cancer, is a member of the heparin-binding growth factor receptor genes","volume":"87","author":"Hattori","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107150750_b38-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1155\/2001\/981218","article-title":"CGH, cDNA and tissue microarray analyses implicate FGFR2 amplification in a small subset of breast tumors","volume":"22","author":"Heiskanen","year":"2001","journal-title":"Anal Cell Pathol"},{"key":"key20180107150750_b39-mco-02-04-0509","first-page":"3541","article-title":"Mutations in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers","volume":"61","author":"Jang","year":"2001","journal-title":"Cancer Res"},{"key":"key20180107150750_b40-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"7591","DOI":"10.1158\/0008-5472.CAN-05-1855","article-title":"Somatic mutations of the protein kinase gene family in human lung cancer","volume":"65","author":"Davies","year":"2005","journal-title":"Cancer Res"},{"key":"key20180107150750_b41-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ygyno.2009.12.002","article-title":"FGFR2 mutations are rare across histologic subtypes of ovarian cancer","volume":"117","author":"Byron","year":"2010","journal-title":"Gynecol Oncol"},{"key":"key20180107150750_b42-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"7158","DOI":"10.1038\/sj.onc.1210529","article-title":"Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes","volume":"26","author":"Pollock","year":"2007","journal-title":"Oncogene"},{"key":"key20180107150750_b43-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1158\/1541-7786.MCR-08-0021","article-title":"Loss-of-function fibroblast growth factor receptor-2 mutations in melanoma","volume":"7","author":"Gartside","year":"2009","journal-title":"Mol Cancer Res"},{"key":"key20180107150750_b44-mco-02-04-0509","first-page":"1373","article-title":"Immunohistochemical detection of K-sam protein in stomach cancer","volume":"2","author":"Hattori","year":"1996","journal-title":"Clin Cancer Res"},{"key":"key20180107150750_b45-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/ijc.24954","article-title":"Focal amplifications are associated with high grade and recurrences in stage Ta bladder carcinoma","volume":"126","author":"Nord","year":"2010","journal-title":"Int J Cancer"},{"key":"key20180107150750_b46-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/path.1900","article-title":"The expression of fibroblast growth factors and their receptors in Hodgkin\u2019s lymphoma","volume":"208","author":"Khnykin","year":"2006","journal-title":"J Pathol"},{"key":"key20180107150750_b47-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1476-4598-4-15","article-title":"Clinical and biological characteristics of cervical neoplasias with FGFR3 mutation","volume":"4","author":"Rosty","year":"2005","journal-title":"Mol Cancer"},{"key":"key20180107150750_b48-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/modpathol.2009.46","article-title":"FGFR3 mutations in prostate cancer: association with low-grade tumors","volume":"22","author":"Hern\u00e1ndez","year":"2009","journal-title":"Modern Pathol"},{"key":"key20180107150750_b49-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/ng.470","article-title":"Activating mutations in FGFR3 and HRAS reveal a shared genetic origin for congenital disorders and testicular tumors","volume":"41","author":"Goriely","year":"2009","journal-title":"Nat Genet"},{"key":"key20180107150750_b50-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.eururo.2007.01.009","article-title":"FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours","volume":"52","author":"van Oers","year":"2007","journal-title":"Eur Urol"},{"key":"key20180107150750_b51-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ejso.2005.11.018","article-title":"FGFR3 and p53 protein expressions in patients with pTa and pT1 urothelial bladder cancer","volume":"32","author":"Mhawrech-Fauceglia","year":"2006","journal-title":"Eur J Surg Oncol"},{"key":"key20180107150750_b52-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"5266","DOI":"10.3748\/wjg.v11.i34.5266","article-title":"Over-expression of fibroblast growth factor receptor 3 in human hepatocellular carcinoma","volume":"11","author":"Qiu","year":"2005","journal-title":"World J Gastroenterol"},{"key":"key20180107150750_b53-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000314346","article-title":"Immunohistochemical detection of fibroblast growth factor receptor 3 in human breast cancer: correlation with clinicopathological\/molecular parameters and prognosis","volume":"77","author":"Kuroso","year":"2010","journal-title":"Pathobiology"},{"key":"key20180107150750_b54-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/med.21288","article-title":"FGF receptors: cancer biology and therapeutics","volume":"34","author":"Katoh","year":"2013","journal-title":"Med Res Rev"},{"key":"key20180107150750_b55-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.canlet.2011.03.015","article-title":"A FGFR2 inhibitor, Ki23057, enhances the chemosensitivity of drug-resistant gastric cancer cells","volume":"307","author":"Qiu","year":"2011","journal-title":"Cancer Lett"},{"key":"key20180107150750_b56-mco-02-04-0509","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1158\/1078-0432.CCR-12-3898","article-title":"FGFR2 gene amplification in gastric cancer predicts sensitivity to the selective FGFR inhibitor AZD4547","volume":"19","author":"Xie","year":"2013","journal-title":"Clin Cancer Res"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mco.2014.293\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T17:55:44Z","timestamp":1716746144000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mco.2014.293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,15]]},"references-count":56,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,5,15]]},"published-print":{"date-parts":[[2014,7]]}},"alternative-id":["10.3892\/mco.2014.293"],"URL":"https:\/\/doi.org\/10.3892\/mco.2014.293","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,15]]}}}